Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IBRX | APGE | ALKS | ||
| Company | Immunitybio Inc | Apogee Therapeutics Inc | Alkermes Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 7.85 | 134.79 | 48.05 | ||
| High | 7.95 | 134.82 | 48.67 | ||
| Low | 7.60 | 134.70 | 47.33 | ||
| Last | 7.79 | 134.75 | 48.33 | ||
| Change | -0.05 | unch | +0.31 | ||
| Percent Change | -0.64% | unch | +0.65% | ||
| Volume | 7,597,700 | 948,200 | 939,600 | ||
| 20-Day Average Volume | 8,819,220 | 1,274,730 | 1,643,895 | ||
| Previous | 7.84 | 134.75 | 48.02 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 7.46 | 134.46 | 49.51 | ||
| 20-Day Raw Stochastic | 70.37% | 84.71% | 15.35% | ||
| 20-Day Relative Strength | 51.60 | 75.66 | 47.20 | ||
| Weighted Alpha | +35.09 | +151.86 | +67.52 | ||
| Today's Opinion | 64% Buy | 100% Buy | 40% Buy | ||
| Yesterday's Opinion | 64% Buy | 100% Buy | 40% Buy | ||
| Last Month's Opinion | 32% Buy | 100% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.91% since 08/14/26 | +0.15% since 08/14/26 | -1.49% since 08/14/26 | ||
| Low | 7.44 on 08/17/26 | 134.51 on 08/17/26 | 47.33 on 08/21/26 | ||
| High | 8.27 on 08/19/26 | 134.88 on 08/19/26 | 51.29 on 08/19/26 | ||
| 1-Month | |||||
| %Chg | -3.47% since 07/21/26 | +0.41% since 07/21/26 | -8.55% since 07/21/26 | ||
| Low | 6.65 on 07/28/26 | 134.02 on 07/23/26 | 47.33 on 08/21/26 | ||
| High | 8.27 on 08/19/26 | 134.88 on 08/19/26 | 53.88 on 07/24/26 | ||
| 3-Month | |||||
| %Chg | +0.65% since 05/21/26 | +63.47% since 05/21/26 | +30.80% since 05/21/26 | ||
| Low | 6.65 on 07/28/26 | 75.86 on 05/27/26 | 36.49 on 05/26/26 | ||
| High | 9.60 on 07/02/26 | 134.88 on 08/19/26 | 55.67 on 07/07/26 | ||
| 6-Month | |||||
| %Chg | -10.46% since 02/20/26 | +97.03% since 02/20/26 | +51.46% since 02/20/26 | ||
| Low | 6.54 on 03/24/26 | 65.22 on 03/20/26 | 27.00 on 03/19/26 | ||
| High | 12.43 on 02/25/26 | 134.88 on 08/19/26 | 55.67 on 07/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,309,115 | 8,381,585 | 8,055,980 | ||
| Shares Outstanding, K | 1,059,836 | 62,201 | 167,763 | ||
| Annual Sales, $M | 113,290,000 | 0 | 1,475,900,000 | ||
| Annual Net Income, $M | -351,400,000 | -255,840,000 | 241,660,000 | ||
| Last Qtr Sales, $M | 51,240,000 | 0 | 496,010,000 | ||
| Last Qtr Income, $M | -230,380,000 | -85,850,000 | 500,000 | ||
| 60-Month Beta | 0.03 | 0.34 | 0.34 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.08 on 08/04/26 | -1.14 on 08/10/26 | 0.00 on 07/28/26 | ||
| Latest Earnings Date | 11/03/26 | 11/09/26 | 10/27/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 116.70 | ||